Edition:
United States

Profile: Zhejiang CONBA Pharmaceutical Co Ltd (600572.SS)

600572.SS on Shanghai Stock Exchange

7.01CNY
20 Feb 2017
Change (% chg)

¥0.06 (+0.86%)
Prev Close
¥6.95
Open
¥6.96
Day's High
¥7.02
Day's Low
¥6.96
Volume
3,864,860
Avg. Vol
13,105,617
52-wk High
¥7.90
52-wk Low
¥6.00

Zhejiang CONBA Pharmaceutical Co., Ltd. is a China-based company engaged in the research, development, production and sale of traditional Chinese medicines, herbal medicines, chemical drugs, bulk drugs and healthcare products. The Company's main products consist of Qianliekang branded tablets and capsules for the treatment of prostatitis; Tianbaoning branded tablets and capsules for the treatment of cardiovascular and cerebrovascular disease; CONBA branded tablets for the treatment of enteritis, as well as Beibei series nutrition liquids for children, among others. The Company distributes its products mainly in domestic markets, with eastern China as its main market.

Company Address

Zhejiang CONBA Pharmaceutical Co Ltd

Binjiang Technological & Eco
No.568 Bnkng Rd,
Hi-Tech Development Zone
HANGZHOU   ZHJ   310052
P: +86571.87774710
F: +86571.87774709

Company Web Links